Filing Details
- Accession Number:
- 0001437749-25-020563
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-06-16 20:23:49
- Reporting Period:
- 2025-06-12
- Filing Date:
- 2025-06-16
- Accepted Time:
- 2025-06-16 20:23:49
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1625101 | Pulse Biosciences Inc. | PLSE | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1276311 | Darrin Uecker | C/O Pulse Biosciences, Inc. 3957 Point Eden Way Hayward CA 94545 | Chief Technology Officer | Yes | Yes | No | No |
Transaction Summary
| Sold: | 30,000 shares | Avg. Price: $16.19 | Total Value: $485,700.00 |
| Number of Shares After Transactions: | 122,872 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2025-06-12 | 15,000 | $16.40 | 137,872 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-06-13 | 15,000 | $15.98 | 122,872 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The price in column 4 is the weighted average price per share sold. The price per share actually received by the Reporting Person ranged from $16.32 to $16.57 per share. For all transactions reported in this Form 4 using a weighted average price, the Reporting Person undertakes upon request by the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares sold at each separate price within the range.
- The price in column 4 is the weighted average price per share sold. The price per share actually received by the Reporting Person ranged from $15.90 to $16.04 per share. For all transactions reported in this Form 4 using a weighted average price, the Reporting Person undertakes upon request by the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares sold at each separate price within the range.
Billionaire Hedge Funds
